Sustained effects of recombinant GH replacement after 7 years of treatment in adults with GH deficiency | Zendy

Agatha A. van der Klaauw | Zendy; Johannes A. Romijn | Zendy; Nienke R. Biermasz | Zendy; Johannes W. A. Smit | Zendy; J. van Doorn | Zendy; Olaf M. Dekkers | Zendy; Ferdinand Roelfsema | Zendy; Alberto M. Pereira | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Sustained effects of recombinant GH replacement after 7 years of treatment in adults with GH deficiency

Author(s) -

Agatha A. van der Klaauw,

Johannes A. Romijn,

Nienke R. Biermasz,

Johannes W. A. Smit,

J. van Doorn,

Olaf M. Dekkers,

Ferdinand Roelfsema,

Alberto M. Pereira

Publication year - 2006

Publication title -

european journal of endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.897

H-Index - 148

eISSN - 1479-683X

pISSN - 0804-4643

DOI - 10.1530/eje.1.02283

Subject(s) - medicine , endocrinology , triglyceride , blood pressure , body mass index , anthropometry , waist , lipoprotein , hormone replacement therapy (female to male) , cholesterol , testosterone (patch)

The goal of GH replacement with recombinant human GH (rhGH) is to ameliorate symptoms, signs, and complications of adult GH deficiency (GHD) in the long term. To determine whether the observed short-term beneficial effects of rhGH treatment are sustained in the long term, we evaluated biochemical and anthropometric parameters after 7 years of rhGH replacement.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research